Merck News Item
12 Nov 2008 ... "The continued success towards elimination of onchocerciasis in the Americas ... more than 2 billion MECTIZAN tablets, at a market value of US$3 billion. ...
Merck & Co., Inc., is a global research-driven pharmaceutical company ... 31,
2007, and in its periodic reports on Form 10-Q and Form 8-K, ...
http://www.merck.com/newsroom/news-release-archive/corporate...
|
Product R&D for neglected diseases
The Special Programme for Research and Training in Tropical Diseases (TDR) was established in ... Of 1450 new chemicals introduced to the global market, only
13 were specifically for .... More than 40 million people are now protected from
onchocerciasis. .... Articles from EMBO Reports are provided here courtesy of
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1326445/...
|
News Release
12 Nov 2008 ... onchocerciasis transmission has been interrupted due to the ... more than 2 billion MECTIZAN tablets, at a market value of US$3 billion. ... Merck & Co.,
Inc. is a global research-driven pharmaceutical company dedicated to ...
periodic reports on Form 10-Q and Form 8-K, which the Company ...
http://www.merck.com/corporate-responsibility/docs/FINAL_IAC...
|
Response from Savioli and Colleagues from the Department of ...
The control of onchocerciasis has freed more than 25 million hectares of previously ... the only effective drug against fascioliasis, has been on the
market for ... also be more balanced in allocating resources to research and
control. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...
|
Merck MECTIZAN® Donation Program
15 Sep 2009 ... Market value of MECTIZAN donations (US$ Million) ... In the 19 countries of the African Program for Onchocerciasis ... In a promising development toward
elimination of river blindness in Africa, WHO's department of Tropical Disease
Research is conducting ... To view the complete report, click here. ...
http://www.merck.com/corporate-responsibility/access/access-...
|
Coordinating health research to promote action: the Tanzanian ...
Both onchocerciasis and malaria were given global priority for eradication, ... and the Population Services International Social Marketing Group as well as
other ... The world health report. Life in the 21st century. A vision for all.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118624/...
|
Publications and Working Papers - Jesse Bump - Takemi Fellow ...
home > Research > Jesse Bump > Publications and Working Papers ... The Role of Trade, Trade Policy and Market Access in Tanzania. ... Improves Skin Condition
and Self-esteem of Females with Onchocerciasis: A Report of Two Case Studies.
... J.B. Bump, "The historical dimensions of Onchocerciasis in Central Africa.
...
http://www.hsph.harvard.edu/research/jesse-bump/publications...
|
Neglected diseases: under-funded research and inadequate health ...
Global Forum for Health Research (2002) The 10/90 Report on Health Research 2001 –2002. ... Molyneux D.H. & Morel C. (1998) Onchocerciasis and Chagas' disease
... (2002) Drug development for neglected diseases: a deficient market and a ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1326440/...
|
Bump CV Sept 2009
Research Assistant, Poverty Reduction and Economic Management Network ... for Onchocerciasis Control.” Under review at the International Journal of Health
Planning & ... and Market Access in Tanzania.” Development Policy Review 25(3):
293–310. ... of Females with Onchocerciasis: A. Report of Two Case Studies. ...
http://www.hsph.harvard.edu/research/jesse-bump/files/Bump_C...
|
[Ivermectin]
More recently ivermectin (under the tradename Stromectol) received market approval in ... Fundamental research will provide a better understanding of the
mode of ... Ivermectin*/therapeutic use; Onchocerca volvulus; Onchocerciasis ...
http://www.ncbi.nlm.nih.gov/pubmed/15903082...
|
